EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uhari, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Uhari, M.
Evidence-Based Medicine 2002; 7:185
© 2002 Evidence-Based Medicine


Therapeutics

Review: Lactobacillus is safe and effective for treating children with acute infectious diarrhoea

Van Niel CW, Feudtner C, Garrison MM, et al.Lactobacillus therapy for acute infectious diarrhoea in children: a meta-analysis.Pediatrics 2002 Apr;109:678–84.[Abstract/Free Full Text]

QUESTION: In children with acute infectious diarrhoea (ID), is treatment with Lactobacillus safe and effective for improving clinical outcomes?

The first 150 words of the full text of this article appear below.

Data sources
Studies were identified by searching Medline, EMBASE/Excerpta Medica, the Cochrane Controlled Trials Register, DARE, and CINAHL from 1966 to 2000, and AMED, MANTIS, the Complementary and Alternative Medicine Citation Index, and AltHealthWatch from 1985–2000. Search terms used were diarrhoea, gastroenteritis, or rotavirus combined with competitive inhibition, Lactobacillus, probiotic, yogurt, or yoghurt. Bibliographies of relevant papers were scanned, and key investigators were contacted.

Study selection
Randomised controlled trials (RCTs) were selected if they involved Lactobacillus treatment of ID in children, clinical outcomes were reported, the treatment group received Lactobacillus and the control group received a suitable placebo, the Lactobacillus and control groups were indistinguishable, and data assessors were blinded to participant treatment group. Studies in which patients had recently received antibiotics were excluded.

Data extraction
Data were extracted on study and participant characteristics, strain of Lactobacillus, definition of diarrhoea, infectious pathogens, adverse effects, and such outcomes as duration and frequency of diarrhoea.

Main results
26 . . . [Full text of this article]

Matti Uhari, MD PhD

University of Oulu
Oulu, Finland







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd.